NINDS phase III investigator-initiated efficacy clinical trials (U01) grant

Funding Opportunity Number: PAR-13-278

The purpose of this Funding Opportunity Announcement (FOA) is to provide a vehicle for submitting grant applications to conduct multi-site, randomized, controlled, Phase 3 clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials may address questions within the mission and research interests of the NINDS. Information about the mission and research interests of the NINDS can be found at the following link.
Check out the latest news and events at CRHC.


Leave a reply

Your email address will not be published. Required fields are marked *